Autism Spectrum Disorder- and/or Intellectual Disability-Associated Semaphorin-5A Exploits the Mechanism by Which Dock5 Signalosome Molecules Control Cell Shape

Bibliographic Details
Title: Autism Spectrum Disorder- and/or Intellectual Disability-Associated Semaphorin-5A Exploits the Mechanism by Which Dock5 Signalosome Molecules Control Cell Shape
Authors: Miyu Okabe, Takanari Sato, Mikito Takahashi, Asahi Honjo, Maho Okawa, Miki Ishida, Mutsuko Kukimoto-Niino, Mikako Shirouzu, Yuki Miyamoto, Junji Yamauchi
Source: Current Issues in Molecular Biology, Vol 46, Iss 4, Pp 3092-3107 (2024)
Publisher Information: MDPI AG, 2024.
Publication Year: 2024
Collection: LCC:Biology (General)
Subject Terms: Sema5A, ASD, Dock5, Elmo2, signalosome, morphogenesis, Biology (General), QH301-705.5
More Details: Autism spectrum disorder (ASD) is a neurodevelopmental disorder that includes autism, Asperger’s syndrome, and pervasive developmental disorder. Individuals with ASD may exhibit difficulties in social interactions, communication challenges, repetitive behaviors, and restricted interests. While genetic mutations in individuals with ASD can either activate or inactivate the activities of the gene product, impacting neuronal morphogenesis and causing symptoms, the underlying mechanism remains to be fully established. Herein, for the first time, we report that genetically conserved Rac1 guanine-nucleotide exchange factor (GEF) Dock5 signalosome molecules control process elongation in the N1E-115 cell line, a model line capable of achieving neuronal morphological changes. The increased elongation phenotypes observed in ASD and intellectual disability (ID)-associated Semaphorin-5A (Sema5A) Arg676-to-Cys [p.R676C] were also mediated by Dock5 signalosome molecules. Indeed, knockdown of Dock5 using clustered regularly interspaced short palindromic repeat (CRISPR)/CasRx-based guide(g)RNA specifically recovered the mutated Sema5A-induced increase in process elongation in cells. Knockdown of Elmo2, an adaptor molecule of Dock5, also exhibited similar recovery. Comparable results were obtained when transfecting the interaction region of Dock5 with Elmo2. The activation of c-Jun N-terminal kinase (JNK), one of the primary signal transduction molecules underlying process elongation, was ameliorated by either their knockdown or transfection. These results suggest that the Dock5 signalosome comprises abnormal signaling involved in the process elongation induced by ASD- and ID-associated Sema5A. These molecules could be added to the list of potential therapeutic target molecules for abnormal neuronal morphogenesis in ASD at the molecular and cellular levels.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1467-3045
1467-3037
Relation: https://www.mdpi.com/1467-3045/46/4/194; https://doaj.org/toc/1467-3037; https://doaj.org/toc/1467-3045
DOI: 10.3390/cimb46040194
Access URL: https://doaj.org/article/22d2af0f322d4eabbf8a1a9c4212a695
Accession Number: edsdoj.22d2af0f322d4eabbf8a1a9c4212a695
Database: Directory of Open Access Journals
More Details
ISSN:14673045
14673037
DOI:10.3390/cimb46040194
Published in:Current Issues in Molecular Biology
Language:English